EXALTA Executive and Leadership Team

Manasi Ramanna, the Chief Financial Officer at EXALTA, directs all fiscal planning and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures alignment between budgetary resources and the manufacturing requirements of the medical device portfolio. This leadership role involves managing investor relations and optimizing the cost structure across North American operations to support long-term growth. By implementing rigorous financial controls, Manasi Ramanna directly impacts the ability of the company to invest in new MedTech innovations. Ultimately, the Chief Financial Officer secures the economic stability necessary for the firm to maintain a competitive edge in the healthcare market. Through precise forecasting and risk management, the Chief Financial Officer provides the foundation for sustainable expansion and operational efficiency, ensuring that every dollar spent contributes to the overarching mission of improving patient care outcomes.

Andrew Thomas, the Chief Operating Officer at EXALTA, manages the end-to-end manufacturing processes and supply chain logistics. Overseeing the production facilities, the Chief Operating Officer ensures that all medical devices meet stringent quality standards while maintaining high output efficiency. This leadership role involves coordinating cross-functional teams to streamline the assembly of complex surgical instruments. By optimizing manufacturing workflows, Andrew Thomas directly impacts the speed at which innovative solutions reach healthcare providers. Ultimately, the Chief Operating Officer drives operational excellence across the entire organization, ensuring that production capacity scales effectively with market demand. Through the integration of advanced manufacturing technologies, the Chief Operating Officer maintains the high-performance standards expected of a leader in the medical device sector, ensuring that every product manufactured supports the company goal of advancing clinical outcomes for patients worldwide.

Jeffrey Tyber, the Group President and Board Member at EXALTA, provides high-level strategic oversight and governance for the entire organization. Overseeing the integration of the founding companies, the Group President and Board Member ensures that the unified entity maintains its focus on delivering innovative surgical solutions. This leadership role involves working closely with the Board to define long-term market positioning and corporate policy. By guiding the executive team, Jeffrey Tyber directly impacts the strategic direction and growth trajectory of the firm. Ultimately, the Group President and Board Member secures the alignment of all business units with the core mission of improving patient care. Through the application of deep industry expertise, the Group President and Board Member navigates the complexities of the global healthcare market, ensuring that the company continues to lead in the development and manufacturing of advanced medical technologies.

David Hannah, the Chief Technology Officer at EXALTA, architects the research and development roadmap for next-generation medical devices. Overseeing the engineering teams, the Chief Technology Officer drives the innovation cycle from initial concept to final product validation. This leadership role involves collaborating with clinical experts to ensure that new technologies address specific surgical challenges and improve patient care. By fostering a culture of technical excellence, David Hannah directly impacts the development of the company product portfolio. Ultimately, the Chief Technology Officer secures the intellectual property and technological superiority of the firm within the competitive MedTech landscape. Through the continuous evaluation of emerging materials and design methodologies, the Chief Technology Officer ensures that the organization remains at the forefront of medical innovation, providing surgeons with the precise tools required to achieve superior clinical results in diverse healthcare environments.

DenaRae Walter, the Chief People Officer at EXALTA, designs the human capital strategy to attract and retain top talent in the medical technology industry. Overseeing organizational development, the Chief People Officer ensures that the workforce possesses the specialized skills required for high-precision medical device manufacturing. This leadership role involves cultivating a corporate culture that prioritizes safety, innovation, and professional growth. By implementing comprehensive training programs, DenaRae Walter directly impacts the productivity and engagement levels of the entire staff. Ultimately, the Chief People Officer aligns the talent strategy with the broader business objectives of the company, ensuring that the organization maintains a high-performing team capable of meeting complex healthcare demands. Through the management of recruitment and employee relations, the Chief People Officer fosters an environment where excellence thrives, supporting the mission to deliver life-enhancing medical solutions to patients and providers.